TY - JOUR
T1 - Relationship among hepatic inflammatory changes, circulating levels of cytokines, and response to IFN-α in chronic hepatitis C
AU - Fabris, Carlo
AU - Soardo, Giorgio
AU - Falleti, Edmondo
AU - Toniutto, Pierluigi
AU - Vitulli, Daniela
AU - Federico, Edda
AU - Del Forno, Monica
AU - Mattiuzzo, Martina
AU - Gonano, Fabio
AU - Pirisi, Mario
PY - 1998/9
Y1 - 1998/9
N2 - To investigate the relationship among circulating cytokines, inflammation in the liver, and kind of response to interferon-α (IFN-α) in hepatitis C, we studied 63 consecutive patients (38 male, 25 female), treated with IFN for up to 1 year. Serum tumor necrosis factor-α (TNF-α) was measured at baseline and after 3 months of treatment. Transient (TR) or sustained response (SR) was observed in 29 and 16 patients, respectively. Baseline levels of TNF ≤22 ng/L were observed in 69% of patients with SR, 55% of patients with TR, and 22% of nonresponders (p < 0.01). There was a significant correlation between baseline TNF levels and histologic grading score of hepatitis (p < 0.01). After 3 months of treatment, TNF levels >22 ng/L were observed in 63% of patients with SR, 69% of patients with TR, and 83% of nonresponders (p NS). Independent of the treatment outcome, TNF levels were lower at baseline and increased significantly with treatment in patients with lower histologic grading (p < 0.005). In conclusion, in patients with chronic hepatitis C, circulating TNF levels correlate with the degree of inflammation in the liver. Response to IFN is accompanied by an inflammatory response involving the release of TNF.
AB - To investigate the relationship among circulating cytokines, inflammation in the liver, and kind of response to interferon-α (IFN-α) in hepatitis C, we studied 63 consecutive patients (38 male, 25 female), treated with IFN for up to 1 year. Serum tumor necrosis factor-α (TNF-α) was measured at baseline and after 3 months of treatment. Transient (TR) or sustained response (SR) was observed in 29 and 16 patients, respectively. Baseline levels of TNF ≤22 ng/L were observed in 69% of patients with SR, 55% of patients with TR, and 22% of nonresponders (p < 0.01). There was a significant correlation between baseline TNF levels and histologic grading score of hepatitis (p < 0.01). After 3 months of treatment, TNF levels >22 ng/L were observed in 63% of patients with SR, 69% of patients with TR, and 83% of nonresponders (p NS). Independent of the treatment outcome, TNF levels were lower at baseline and increased significantly with treatment in patients with lower histologic grading (p < 0.005). In conclusion, in patients with chronic hepatitis C, circulating TNF levels correlate with the degree of inflammation in the liver. Response to IFN is accompanied by an inflammatory response involving the release of TNF.
UR - http://www.scopus.com/inward/record.url?scp=17644445005&partnerID=8YFLogxK
U2 - 10.1089/jir.1998.18.705
DO - 10.1089/jir.1998.18.705
M3 - Article
SN - 1079-9907
VL - 18
SP - 705
EP - 709
JO - Journal of Interferon and Cytokine Research
JF - Journal of Interferon and Cytokine Research
IS - 9
ER -